BRIEF-Prometic Life Sciences to acquire Telesta Therapeutics
Aug 24 (Reuters) - ProMetic Life Sciences Inc :
* ProMetic announces agreement to acquire Telesta Therapeutics Inc in all share transaction
* Will acquire all of share capital of Telesta at a share price of $0.14 payable in ProMetic common shares
* Deal does not materially affect ProMetic's EBITDA and operating cash flows
* Agreement also contains no shop provisions and a mutual $2.5 million breakup fee payable by Telesta or ProMetic in specified circumstances Source text for Eikon: Further company coverage:
© Thomson Reuters 2017 All rights reserved.